About: Second Genome     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : dbo:Organisation, within Data Space : dbpedia.org associated with source document(s)
QRcode icon
http://dbpedia.org/describe/?url=http%3A%2F%2Fdbpedia.org%2Fresource%2FSecond_Genome

Second Genome is a venture capital funded, life sciences research company based in South San Francisco. The company's focus is on the development and exploitation of a research platform which facilitates the identification and elucidation of relationships between human physiology and the human microbiota, and it has a long term goal of becoming a drug development company. The name "second genome" comes from the notion that humans have, effectively, two genomes: the native human genome, and the more diverse set of genomes carried by the human microbiota.

AttributesValues
rdf:type
rdfs:label
  • Second Genome (en)
rdfs:comment
  • Second Genome is a venture capital funded, life sciences research company based in South San Francisco. The company's focus is on the development and exploitation of a research platform which facilitates the identification and elucidation of relationships between human physiology and the human microbiota, and it has a long term goal of becoming a drug development company. The name "second genome" comes from the notion that humans have, effectively, two genomes: the native human genome, and the more diverse set of genomes carried by the human microbiota. (en)
foaf:name
  • Second Genome (en)
name
  • Second Genome (en)
dcterms:subject
Wikipage page ID
Wikipage revision ID
Link from a Wikipage to another Wikipage
Link from a Wikipage to an external page
sameAs
dbp:wikiPageUsesTemplate
founder
  • (en)
  • Corey Goodman (en)
  • Todd DeSantis (en)
key people
  • Peter DiLaura (en)
num employees
has abstract
  • Second Genome is a venture capital funded, life sciences research company based in South San Francisco. The company's focus is on the development and exploitation of a research platform which facilitates the identification and elucidation of relationships between human physiology and the human microbiota, and it has a long term goal of becoming a drug development company. The name "second genome" comes from the notion that humans have, effectively, two genomes: the native human genome, and the more diverse set of genomes carried by the human microbiota. The company's first foray into drug development was a small molecule treatment for ulcerative colitis (SGM-1019). The mechanism of SGM-1019 has not been disclosed in detail. Key to the company's business model has been partnerships with large established pharmaceutical companies, including Pfizer and Janssen. Potential competitors to Second Genome include Kaleido Biosciences, Synlogic, Kallyope, Seres Therapeutics, OpenBiome, Rebiotix, Evelo Therapeutics, and Vedanta Biosciences. Second Genome was founded in 2010 by Corey Goodman, a venture capitalist and former Pfizer executive, and Todd DeSantis, the company's vice president for informatics as of 2019. As of 2013, the company had entered into an ulcerative colitis research agreement with Janssen, the financial arrangement and outcome of which remains to be determined. The company had a headcount of 18 employees as of 2014, which had increased to 25 by 2016. Startup financing was obtained through a Series A round which raised US$11.5 million. A Series B round of funding raised US$42.6 million in 2016. By 2016, the company had established a DNA sequencing service aimed at microbial samples, which provided revenue to supplement venture capital infusions. As of 2019, the company had secured a two-year SBIR grant in collaboration with Oregon State University, aimed at studying microbiome metabolites from people suffering from nervous system disorders, in particular autism. As of 2016, the company's president and chief executive officer was Peter DiLaura. (en)
prov:wasDerivedFrom
page length (characters) of wiki page
number of employees
foaf:isPrimaryTopicOf
is Link from a Wikipage to another Wikipage of
is foaf:primaryTopic of
Faceted Search & Find service v1.17_git139 as of Feb 29 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 08.03.3330 as of Mar 19 2024, on Linux (x86_64-generic-linux-glibc212), Single-Server Edition (378 GB total memory, 60 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software